JP2006528209A - 火傷に対する二次的な全身的損傷の処置方法 - Google Patents

火傷に対する二次的な全身的損傷の処置方法 Download PDF

Info

Publication number
JP2006528209A
JP2006528209A JP2006529451A JP2006529451A JP2006528209A JP 2006528209 A JP2006528209 A JP 2006528209A JP 2006529451 A JP2006529451 A JP 2006529451A JP 2006529451 A JP2006529451 A JP 2006529451A JP 2006528209 A JP2006528209 A JP 2006528209A
Authority
JP
Japan
Prior art keywords
side chain
alkyl
aryl
compound
burns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006529451A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006528209A5 (enExample
Inventor
イアン・アレキサンダー・シールズ
スティーブン・マックスウェル・テイラー
シェリー・ゼット・ストックス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland
Original Assignee
University of Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland filed Critical University of Queensland
Publication of JP2006528209A publication Critical patent/JP2006528209A/ja
Publication of JP2006528209A5 publication Critical patent/JP2006528209A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
JP2006529451A 2003-05-26 2004-05-26 火傷に対する二次的な全身的損傷の処置方法 Withdrawn JP2006528209A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003902586A AU2003902586A0 (en) 2003-05-26 2003-05-26 Treatment of burns
PCT/AU2004/000703 WO2004103392A1 (en) 2003-05-26 2004-05-26 Method of treatment of systemic injury secondary to burns

Publications (2)

Publication Number Publication Date
JP2006528209A true JP2006528209A (ja) 2006-12-14
JP2006528209A5 JP2006528209A5 (enExample) 2007-07-12

Family

ID=31953629

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006529451A Withdrawn JP2006528209A (ja) 2003-05-26 2004-05-26 火傷に対する二次的な全身的損傷の処置方法

Country Status (6)

Country Link
US (1) US20070054841A1 (enExample)
EP (1) EP1641482A1 (enExample)
JP (1) JP2006528209A (enExample)
AU (1) AU2003902586A0 (enExample)
CA (1) CA2557625A1 (enExample)
WO (1) WO2004103392A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS160602A0 (en) * 2002-04-08 2002-05-16 University Of Queensland, The Therapeutic method
ATE509632T1 (de) * 2002-10-16 2011-06-15 Promics Pty Ltd Behandlung von entzündlicher darmerkrankung
AU2002952086A0 (en) * 2002-10-16 2002-11-07 The University Of Queensland Treatment of osteoarthritis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO755097A0 (en) * 1997-06-25 1997-07-17 University Of Queensland, The Receptor agonist and antagonist
AUPR833401A0 (en) * 2001-10-17 2001-11-08 University Of Queensland, The G protein-coupled receptor antagonists
AU2002952129A0 (en) * 2002-10-17 2002-10-31 The University Of Queensland Treatment of hypersensitivity conditions

Also Published As

Publication number Publication date
US20070054841A1 (en) 2007-03-08
WO2004103392A1 (en) 2004-12-02
CA2557625A1 (en) 2004-12-02
EP1641482A1 (en) 2006-04-05
AU2003902586A0 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
AU2007283514B2 (en) Polymyxin derivatives and uses thereof
JP2011241214A (ja) 線維症の処置におけるＣ５ａ受容体アンタゴニストの使用
ES2638589T3 (es) Tratamientos para trastornos intestinales
AU2009211287A1 (en) Short fatty acid tail polymyxin derivatives and uses thereof
US20090004264A1 (en) Methods for treating and ameliorating the symptons of inflammatory bowel diseases
JP6518197B2 (ja) バース症候群の予防または治療のための方法及び組成物
US20180296632A1 (en) Use of peptides to stimulate the immune system
PT1919947E (pt) Análogos de α-msh terapeuticamente activos
JP2006528208A (ja) コンプリメント５ａ受容体阻害剤を使用する出血ショックの処置
RU2470666C2 (ru) Фармацевтическая композиция для трансназального введения
US20070054841A1 (en) Method of treatment of systemic injury secondary to burns
JP4950903B2 (ja) ボンベシン／ガストリン放出ペプチドアンタゴニストの、炎症性状態、急性肺損傷及び双極性障害の治療のための使用
JP3472821B2 (ja) 新規ペプチド、及び当該ペプチドを用いた組成物
AU2004241673A1 (en) Method of treatment of systemic injury secondary to burns
ES2366538T3 (es) Tratamiento de la enfermedad inflamatoria intestinal.
US12194034B2 (en) Neutrophil exocytosis inhibitors
AU2003215446B2 (en) Use of C5a receptor antagonist in the treatment of fibrosis
AU2003269602B2 (en) Treatment of inflammatory bowel disease
AU2013257422B2 (en) Short fatty acid tail polymyxin derivatives and uses thereof
CN111163793A (zh) 血管紧张素受体激动剂及其用途
BR112019012597A2 (pt) inibidores de glutaminil ciclase e uso dos mesmos em tratamento de várias doenças
AU2003269602A1 (en) Treatment of inflammatory bowel disease
MX2008002641A (es) Analogos de a-msh terapeuticamente activos

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070528

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070528

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20080520